LTGO Stock Summary and Trading Ideas (Latigo Biotherapeutics | NASDAQ:LTGO)

Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.

What symbol and exchange does Latigo Biotherapeutics shares trade?

Latigo Biotherapeutics trades on the NASDAQ stock market under the symbol LTGO.

What is Latigo Biotherapeutics stock price doing today?

As of September 4, 2026, LTGO stock price climbed to $23.04 with 221,304 million shares trading.

How much is Latigo Biotherapeutics worth?

LTGO has a market cap of $1.46 billion. This is considered a Small Cap stock.

What are the support and resistance levels for Latigo Biotherapeutics (LTGO)?

LTGO support price is $21.33 and resistance is $23.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LTGO shares will trade within this expected range on the day.